Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Larson Tina Marriott, Chief Operating Officer. Insider active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 27 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €48k. Activity tracked since 18 November 2021. The latest transaction was disclosed on 25 January 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Larson Tina Marriott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
79,613 shares0Class A Common StockSEC:0001209191-22-007911:0
25 of 27 declarations
About Larson Tina Marriott
Larson Tina Marriott is President and COO at Recursion Pharmaceuticals, INC. (XNAS). She has 27 filings in total, and across the 27 sampled filings from 2021-11-22 to 2024-01-29, sales total EUR 48465, with Option exercise as the modal transaction nature.